---
document_datetime: 2025-04-24 14:57:24
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/kisqali-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: kisqali-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 1.2490381
conversion_datetime: 2025-12-30 03:31:12.924116
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Kisqali

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, please also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | C.I HUMAN AND VETERINARY MEDICINAL | 24/04/2025                          |                                             | SmPC                             |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000261091   | PRODUCTS - C.I.z Implementation of an agreed wording, no new data submitted - Accepted C.I.z - To update section 5.1 of the SmPC by removing the words \"(excluding microscopic nodal involvement)\" since this wording inaccurately reflects the population included in the Pivotal clinical trial (Procedure No. EMEA/H/C/004213/II/0045).   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|